12:00 AM
 | 
Jun 01, 1999
 |  BC Week In Review  |  Company News  |  Deals

Algene, Genset deal

AGN.B will exclusively license to GENSET Alzheimer's disease (AD) DNA collections and gene mapping results that AGN.B has compiled from a phenotyped collection of samples from AD patients within the Quebec...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >